Medical and Pharmaceutical
SynCardia's Total Artificial Heart serves as a temporary solution while patients wait for donors
Hi, what are you looking for?
Mugglehead Investment Magazine
Stock News
Stock News
The leading firm is expecting to raise US$900M from its long-awaited public launch
Stock News
ChangXin Memory Technologies is now worth over US$475 billion
Stock News
The firm's assessments have an influential track record
Stock News
It just surged above 68,000 for the first time
Medical and Pharmaceutical
The oncology and biotech firm has secured approximately US$22.5 million
Stock News
The company has been making a comeback since its 2023 bankruptcy
Cannabis
Compliance issues, low trading volume and other problems prompted the move
Psychedelics
The financial institution has given the drug developer a Buy rating a US$12 share target
Gold
The gold producer has gone six years without a lost time incident at the Nevada mine site
